Depo-Provera Lawsuit – Act Now!

Depo-Provera (medroxyprogesterone acetate) is a hormonal contraceptive that is administered via injection every three months.

However, prolonged use of this medication, particularly beyond one year, has been linked to the development of tumors known as meningiomas in the brain or spine.

Research published in The BMJ indicates that women using Depo-Provera are five times more likely to develop these tumors.

Despite being aware of this significant risk, Pfizer, the drug’s manufacturer, has not revised the warning label for Depo-Provera to adequately inform patients. Those who have been affected may have grounds to pursue a lawsuit against the company for cancer-related claims.

Overview of Depo-Provera Lawsuit Information

Depo-Provera has been a widely utilized contraceptive method globally for nearly six decades. The U.S. Food and Drug Administration (FDA) granted approval for Depo-Provera’s use in the United States in October 1992.

Each year, approximately one to two million women in the U.S. rely on Depo-Provera for contraception. It is estimated that around 20% of women in America have utilized Depo-Provera at some stage in their lives.

In the United States, the recommended dosage is 150 mg administered via intramuscular injection into the buttock or upper arm every three months.

Depo-Provera Lawsuit –

Who is eligible?

You may have the opportunity to file a lawsuit related to the Depo-Provera shot if you or someone close to you has:

– Used Depo-Provera, Depo-SubQ Provera 104, or any approved generics

– Developed an intracranial meningioma, a specific type of brain or spine tumor

– Undergone surgery or radiation treatment, or have such treatments planned

It is important to be aware that there is a limited timeframe to file a lawsuit concerning a Depo-Provera-related brain tumor, dictated by state statutes of limitations.

Once the deadline for your case has elapsed, you will lose the chance to pursue legal action and seek compensation for your injuries.